We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBalfour Beatty Regulatory News (BBY)

Share Price Information for Balfour Beatty (BBY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 364.60
Bid: 364.40
Ask: 365.00
Change: 0.00 (0.00%)
Spread: 0.60 (0.165%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 364.60
BBY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re clarification

15 Aug 2014 07:00

RNS Number : 2382P
Balfour Beatty PLC
15 August 2014
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

 

THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO UNDERTAKE ANY TRANSACTION UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT ANY TRANSACTION WILL PROCEED NOR AS TO THE TERMS OF ANY TRANSACTION

 

FOR IMMEDIATE RELEASE

 

15 August 2014

 

Balfour Beatty plc

 

STATEMENT BY BALFOUR BEATTY

 

Balfour Beatty refers to a statement in its announcement of 14 August, that "to benchmark a series of theoretical cost reduction opportunities, represent them all as synergies, and further, to represent them as incremental value creation directly arising from Carillion's merger proposal is incorrect".

 

By way of clarification, this statement refers to a number of specific issues, which Balfour Beatty has also clarified in another statement made today. First, the fact that the benchmarking methodology adopted was not based on actual information on Balfour Beatty's cost base, as Carillion did not have access to that information; secondly, Balfour Beatty disagrees with Carillion's assertion that all of the cost savings can be represented as synergies, because some are partly based on a reduction in revenues in the Balfour Beatty UK construction business, which is something Balfour Beatty could do on its own. Balfour Beatty believes that these synergies should not be regarded as cost savings which will only accrue as a direct result of the merger; and thirdly, Balfour Beatty disagrees with the basis on which Carillion has calculated the incremental value creation attributed to the cost savings as it does not reflect the associated costs; for example the one off costs of approximately £225 million, the value leakage from transaction and financing fees, and the net present value of working capital outflows. The statement was a summary of these three issues, and was not intended to suggest that the Quantified Financial Benefits Statement, prepared on the basis set out by Carillion, or the reports upon it set out in the announcement by Carillion dated 14 August were incorrect.

 

Enquiries:

Balfour Beatty

 

Anoop Kang, Head of Investor Relations+44 (0) 20 7216 6913

anoop.kang@balfourbeatty.comPatrick Kerr, Director of Corporate Communications+44 (0) 20 7963 4258

patrick.kerr@balfourbeatty.com

 

Goldman Sachs (Lead Financial Adviser and Corporate Broker to Balfour Beatty)

Anthony Gutman

Philip Shelley

Owain Evans

+44 (0) 20 7774 1000

 

BofA Merrill Lynch (Joint Financial Advisor and Corporate Broker to Balfour Beatty)

Michael Findlay

Justin Anstee

Georgina Stober

+44 (0) 20 7628 1000

 

Maitland

Liz Morley

James Isola

+44 (0) 20 7379 5151

 

Directors' Responsibility Statement

The Directors of Balfour Beatty accept responsibility for the information contained in this document. To the best of the knowledge and belief of the Directors, who have taken all reasonable care to ensure such is the case, the information contained in this document is in accordance with the facts and does not omit anything likely to affect the import of such information.

 

This announcement is for information purposes only and does not constitute an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy any securities, pursuant to the offer or otherwise.

 

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

 

Publication on website

A copy of this announcement will be made available subject to certain restrictions relating to persons resident in restricted jurisdictions on Balfour Beatty's website at www.balfourbeatty.com by no later than 12 noon (London time) on 18 August 2014.

 

The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Further information

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting as financial adviser to Balfour Beatty and no one else in connection with the matters referred to in this announcement. In connection with such matters Goldman Sachs International, its affiliates and its and their respective directors, officers, employees and agents will not regard any other person as their client, nor will they be responsible to anyone other than Balfour Beatty for providing the protections afforded to clients of Goldman Sachs International, or for giving advice in connection with the contents of this announcement or any other matter referred to herein.

 

Merrill Lynch International ("BofA Merrill Lynch"), a subsidiary of Bank of America Corporation, is acting exclusively for Balfour Beatty in connection with the matters referred to in this announcement and for no one else and will not be responsible to anyone other than Balfour Beatty for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement or any other matter referred to herein.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. THIS ANNOUNCEMENT DOES NOT CONSTITUTE A TAKEOVER OFFER OR AN OFFER OF SECURITIES. NO OFFER OR SALE OF SECURITIES MAY OCCUR IN THE UNITED STATES UNLESS THE TRANSACTION HAS BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933 (THE "SECURITIES ACT") OR IS EXEMPT FROM REGISTRATION THEREUNDER. NO SECURITIES HAVE BEEN OR WILL BE REGISTERED UNDER THE SECURITIES ACT AND THERE WILL BE NO PUBLIC OFFER OF SECURITIES IN THE UNITED STATES.

 

APPENDIX I

SOURCES AND BASES

 

Unless otherwise stated, financial and other information concerning Balfour Beatty has been extracted from publicly available sources or from Balfour Beatty's management sources.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLIFVETSIELIS
Date   Source Headline
23rd Apr 20247:10 amRNSTransaction in Own Shares
22nd Apr 20247:10 amRNSTransaction in Own Shares
19th Apr 20247:10 amRNSTransaction in Own Shares
18th Apr 20247:10 amRNSTransaction in Own Shares
17th Apr 20247:10 amRNSTransaction in Own Shares
16th Apr 20247:10 amRNSTransaction in Own Shares
15th Apr 20247:10 amRNSTransaction in Own Shares
12th Apr 20247:10 amRNSTransaction in Own Shares
11th Apr 20247:10 amRNSTransaction in Own Shares
10th Apr 20247:10 amRNSTransaction in Own Shares
9th Apr 20247:10 amRNSTransaction in Own Shares
8th Apr 20245:28 pmRNSDirector Declaration
8th Apr 20247:10 amRNSTransaction in Own Shares
5th Apr 20247:10 amRNSTransaction in Own Shares
4th Apr 20247:10 amRNSTransaction in Own Shares
3rd Apr 20243:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20249:00 amRNSAnnual Financial Report
3rd Apr 20247:10 amRNSTransaction in Own Shares
2nd Apr 20247:10 amRNSTotal Voting Rights
2nd Apr 20247:10 amRNSTransaction in Own Shares
28th Mar 20243:27 pmRNSDirector/PDMR Shareholding
28th Mar 20247:10 amRNSTransaction in Own Shares
27th Mar 20247:10 amRNSTransaction in Own Shares
26th Mar 20247:10 amRNSTransaction in Own Shares
25th Mar 20247:10 amRNSTransaction in Own Shares
22nd Mar 20247:10 amRNSTransaction in Own Shares
21st Mar 202412:04 pmRNSDirector/PDMR Shareholding
21st Mar 20247:10 amRNSTransaction in Own Shares
20th Mar 20247:10 amRNSTransaction in Own Shares
19th Mar 20247:10 amRNSTransaction in Own Shares
18th Mar 20247:10 amRNSTransaction in Own Shares
15th Mar 20247:10 amRNSTransaction in Own Shares
13th Mar 20247:10 amRNSShare Buyback Programme
13th Mar 20247:10 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSBALFOUR BEATTY 2023 FULL YEAR RESULTS
12th Mar 20247:10 amRNSTransaction in Own Shares
11th Mar 20247:10 amRNSTransaction in Own Shares
8th Mar 20247:10 amRNSTransaction in Own Shares
7th Mar 20247:10 amRNSTransaction in Own Shares
6th Mar 20247:10 amRNSTransaction in Own Shares
5th Mar 20247:10 amRNSTransaction in Own Shares
4th Mar 20247:10 amRNSTransaction in Own Shares
1st Mar 20247:10 amRNSTotal Voting Rights
1st Mar 20247:10 amRNSTransaction in Own Shares
29th Feb 20247:10 amRNSTransaction in Own Shares
28th Feb 20247:10 amRNSTransaction in Own Shares
27th Feb 20247:10 amRNSTransaction in Own Shares
26th Feb 20243:51 pmRNSHolding(s) in Company
26th Feb 202410:00 amRNSAppointment - Senior Independent Non-Exec Director
26th Feb 20247:10 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.